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Background: Early weaning (EW) results in a transient period of impaired integrity of the intestinal mucosa that
may be associated with reduced plasma concentration of glucagon-like peptide-(GLP) 2. We have previously shown that
intragastric infusion of chenodeoxycholic acid (CDC) increases circulating GLP-2 in early-weaned piglets. The aim of this
study was to expand previous work to establish whether feeding piglets a cereal-based diet supplemented with CDC can
improve gut integrity and animal performance immediately after EW. A cohort of 36 piglets weaned at 20 days of age,
6.2 ± 0.34 kg of body weight (BW) were randomly assigned (n= 18) to receive a standard prestarter diet or the same diet
supplemented with 60 mg of CDC per kg of initial BW for ad libitum intake until day 14 postweaning. Thereafter, all pigs
were fed the same untreated starter diet for 21 days until the end of the study on day 35. On days 1, 7 and 14 blood
samples were collected from 6 pigs per treatment to measure plasma GLP-2. On day 15, 6 pigs per treatment were
euthanized to obtain intestinal tissue samples for later histological and gene expression analyses.
Results: Supplementing the diet with CDC tended to increase plasma GLP-2 (P < 0.07; 39 %) and the weight of the large
intestine (P < 0.10; 11 %), and increased ileal crypt depth (P < 0.04; 15 %) after 14 days of treatment exposure. Although
feed intake and BW gain were not affected by treatments, feeding CDC induced the expression of the cytokines TNF-α
(P < 0.02; 1.9 fold), IL-6 (P < 0.01; 2.4 fold), and IL-10 (P < 0.006; 2.2 fold) and the tight junctional protein ZON-1
(P < 0.02; 1.5 fold) in the distal small intestine.
Conclusions: This study showed that the oral administration of CDC to early-weaned pigs has the potential to
improve the protection of the intestinal mucosa independently of relevant changes in gut growth.
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Early weaning (EW) is a widespread practice in modern
settings of pig production. At that time, piglets are ex-
posed to a variety of stressors including abrupt separ-
ation from sow and changes in diet and environment,
which jointly result in a period of transient anorexia, gut
mucosal atrophy, and intestinal dysfunction [1–3]. The
weaning-induced deterioration of gut integrity could be
partly related to the marked reduction in circulating
glucagon-like peptide (GLP)-2 that typically accompan-
ies EW in pigs [4, 5].
GLP-2 is an intestinotrophic peptide released by the
enteroendocrine L cells mainly in response to luminal* Correspondence: ignacio.ipharraguerre@lucta.com
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article, unless otherwise stated.nutrients [6, 7]. Of interest, exogenous GLP-2 restores
mucosal growth, transcellular transport, and the expres-
sion of tight junction (TJ) proteins that control para-
cellular permeability in a number of animal models of
intestinal atrophy or dysfunction [8–10]. Recently, it has
been found that the chronic administration of GLP-2 at
supraphysiological levels to neonatal pigs for 42 days in-
creased villus height and crypt depth in the small intes-
tine and colon 21 days after EW [11]. More important,
the administration of a long-acting analog of GLP-2 at
pharmacological doses to 25-days-old suckling piglets
increased intestinal weight and enzyme activity 5 days
after weaning [12]. Although available evidence suggests
that GLP-2 treatment can contribute to improve intes-
tinal adaptation to weaning, it is reasonable to expect
that strategies capable of enhancing secretion and (or)
stability of endogenous GLP-2 might be equally effectived Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 Composition of the prestarter and the starter diets, %






Extruded soybeans 14.6 5.0
Soybean meal (56 % CP) 4.2 -
Soybean meal (47 % CP) - 13.7
Sweet milk whey powder 12.6 2.94
Fishmeal 7.0 5.0
Soybean oil 4.0 -
Lard - 2.06
Trace elements and vitamin premix1 1.55 1.52
Calcium carbonate 0.82 0.50











Methionine + cysteine 0.72 0.62
Threonine 0.76 0.64
Tryptophan 0.23 0.22
Digestible energy (MJ/kg) 14.9 14.4
Net energy (MJ/kg) 11.2 10.3
1Containing the following: vitamin A, 10,000 UI; vitamin D3, 2000 UI; vitamin E
(alfa-tocopherol), 25 mg; vitamin B1, 1.5 mg; vitamin B2, 3.5 mg; vitamin B6,
2.4 mg; vitamin B12, 20 μg; vitamin K3, 1.5 mg; calcium panthotenate, 14 mg;
nicotinic acid, 20 mg; folic acid, 0.5 mg; biotin, 50 μg; iron sulfate, 120 mg; calcium
iodate, 0.75 mg; cobalt carbonate, 0.6 mg; copper sulfate, 150 mg; manganesium
oxide, 60 mg; zinc oxide, 110 mg; sodium selenite, 0.37 mg; amoxycilin trihidrate
10 %, 300 mg; colistin sulphate 4 %, 80 mg; zinc oxide, 2.610 mg
2Ileal standardized digestibility
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pig production.
In recent years bile acids have emerged as potent hor-
monal regulators capable of stimulating the secretion of
GLP-1 (a co-product of proglucagon, released in parallel
with GLP-2) from the intestine. This action is mediated
by the G-protein-coupled bile acid receptor 1 (GPBAR1,
also known as TGR5), which is a bile acid sensor
expressed on the luminal surface of intestinal L cells [13,
14]. Interestingly, the continuous enteral administration
of chenodeoxycholic acid (CDC), a primary bile acid
known to activate TGR5, to newborn piglets fed paren-
terally increased the plasma concentration of GLP-2 and
prevented gut atrophy otherwise resulting from the lack
of enteral nutrition [15]. In a later study, we investigated
whether CDC could induce a similar response in wean-
ling pigs. In this study, piglets weaned at 21 days of age,
fed a cereal-based diet, and infused intragastrically with
a single dose of CDC had increased circulating GLP-2
and tended to have a longer and heavier intestine than
their control counterparts [16]. As proposed in that re-
port, it is plausible that the dose of CDC and adminis-
tration procedure used in our study might have limited
the impact of increased GLP-2 secretion on intestinal
adaptation to EW. It is important to note, however, that
bile acids may also control the integrity of the intestinal
barrier by regulating the expression or cellular distribu-
tion of TJ proteins through mechanisms unrelated to
GLP-2 [17, 18].
In summary, available evidence indicates that activat-
ing intestinal signaling pathways controlled by bile acids
allows stimulating the release of endogenous GLP-2 and
thereby improving gut integrity in experimental models
of intestinal atrophy and dysfunction. Therefore, the aim
of this study was to expand previous work to establish
whether the inclusion of CDC in the diet of early-
weaned piglets fed according to current standards of pig
production can improve gut integrity and animal per-
formance immediately after weaning.
Methods
Animals and housing
All experimental procedures were approved by the
Laboratory Animal Care Advisory Committee of the
Faculty of Veterinary Sciences of the Universitat Autónoma
de Barcelona, Spain. A total of 36 pigs (Large White x
Landrace x Pietrain; 18 of each sex) weaned at 20 ± 0.9 days
of age and 6.2 ± 0.34 kg of body weight (BW) were used in
a study conducted at the Swine Experimental Unit of Lucta
S.A. (Girona, Spain). At arrival, piglets were distributed into
36 individual pens (0.35 m2/pen) thoroughly cleaned and
equipped with fully-slatted plastic floor plus a nipple
drinker and a feeder. Animals were randomly assigned to
receive a standard prestarter diet (CONd; n = 18; 50:50male to female ratio) or the same diet supplemented with
60 mg of CDC (Sigma-Aldrich) per kg of initial BW
(CDCd). Animals were fed the solid diets from weaning
until day 14; thereafter, all pigs were fed the same (un-
treated) starter diet for 21 days until the end of experi-
ment on day 35 (Table 1). During the study, all pigs
had ad libitum access to feed and water. Starting at
weaning BW was measured weekly, whereas feed in-
take was recorded daily until day 13 and weekly from
day 15 to 35.
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Blood samples were obtained from six randomly-chosen
pigs per treatment via jugular venipuncture on day 1, 7,
and 14 after 12 h of feed deprivation. Samples were col-
lected into tubes containing EDTA and aprotinin (BD
Vacutainer®), held in ice-cold water for 30 min, centri-
fuged at 2000 × g for 10 min, stored at −80 °C, and ana-
lyzed later on for bioactive GLP-2 by radioimmunoassay
as described previously [19].
Tissue collection
On day 15 after 3 h of feed deprivation, 6 pigs per treat-
ment were euthanized with an intravenous injection of
sodium pentobarbital (200 mg per kg of BW; Fatro Ibér-
ica, Spain). The abdomen was opened and the intestines
were removed and dissected into sections arbitrary des-
ignated as jejunum (from the pyloric sphincter to the
first Peyer’s patch), ileum (from the first Peyer’s patch to
the ileocecal valve) and large intestine (from the ileocecal
valve to the rectum). Intestinal sections were measured,
flushed with saline, and weighted. A 10-cm segment was
removed from the midsection of the jejunum and ileum,
divided into 5-cm halves, and opened longitudinally. Half
of these samples were fixed in 10 % buffered formalin for
subsequent histological examination, whereas mucosal
scrapings were taken from the other half and stored in
RNAlater® (Ambion, USA) at −80 °C until analysis of gene
expression.
Morphometric analysis
Samples of jejunum and ileum were dehydrated and em-
bedded in paraffin, sectioned (~4 μm), and stained with
hematoxylin and eosin. Villus height, crypt depth, num-
ber of intraepithelial lymphocytes in villi, and number of
goblet cells in crypts were measured in 10 well-oriented
villi and crypts using a light microscope (BHS, Olympus)
and a linear ocular micrometer (Olympus, Microplanet).
All determinations were done by the same person, who
was blinded to treatments, at 400× magnification as de-
scribed previously [20].
Real-time RT-qPCR analysis
Total RNA from intestinal mucosal scrapings was ex-
tracted and first strand cDNA synthesized as previously
described [16]. Approximately 2 μg of RNA with an
average A260/A280 of 1.9 were retrotranscribed. Primers
and optimal PCR conditions for porcine interleukin-10
(IL-10), tumor necrosis factor alpha (TNF-α), glucagon-
like peptide-2 receptor (GLP-2R), proglucagon (GCG),
sodium-dependent bile acid transporter (ASBT), tata
box-binding protein (TBP), beta actin (ACTB) [16], zonula
occludens-1 (ZON-1), occludin (OCLN) [21] epidermal
growth factor receptor (EGFR) [22] and interleukin-6
(IL-6) [23] were taken from literature. These genes werepreviously shown to play a role in mediating the effects
of bile acids on gut mucosal inflammation and barrier
function [16–18]. Gene expression was determined in
the jejunum and ileum, except for EGFR and IL-6 that
were examined only in ileal samples. All samples were
run in triplicate in an ABI Prism 7300 Sequence De-
tector System (Applied Biosystems) using SYBR Green
Master Mix (Applied Biosystems) and specific primers
for each gene, as previously described [16].
Statistical analysis
Analyses were performed using the mixed-model pro-
cedure of SAS (release 9.2, SAS Institute Inc.). Perform-
ance data (BW, average daily gain, feed intake and feed
conversion) for animals that were slaughtered on day 15
(n = 6) and those that completed the study on d 35
(n = 12) were analyzed separately. These results and
GLP-2 data were analyzed using a mixed-effect model
with repeated measures in which pig within treatment
was used as random variable whereas treatment, time
(day or week), and the interaction treatment by time
were considered fixed. The smallest value for the
Akaike’s information criterion was used to identify the
most appropriate covariance structure. The same model
but without repeated measures was used to analyze in-
testinal weight, length, and morphology. To achieve
normality, data for GLP-2 were transformed prior to
analysis. Least squares means were separated into signifi-
cant effects using the Fisher adjustment option of SAS.
Differences in gene expression resulting from the com-
parison of the CDCd group with the CONd group were
determined using a linear mixed-model in which treat-
ment was included as fixed effect and the sample as
random [24]. Gene specific residual variance (heteroge-
neous residual) was fitted to the gene effect [25]. For
genes displaying efficiencies different from 2 (E ≠ 2), Ct
values were adjusted according to the model described
by Steibel et al. [24]. The geometric mean of the refer-
ence genes TBP and ACTB was used to correct Ct values
of target genes [26]. Differences among treatments were
considered to be significant when P < 0.05, whereas
when P > 0.05 but < 0.10 differences were considered to
indicate a trend towards a significant effect.
Results
Animal performance
The onset of feed consumption after weaning and its
time course during both the first 13 days of exposure to
treatments (Fig. 1) and the 5 weeks of study (Fig. 2) were
similar between treatment groups. Likewise, supplement-
ing the CONd prestarter diet with CDC did not alter
weight gain of piglets that ended the study either on
days 15 or 35 (Table 2). In both treatment groups the in-
cidence of diarrhea was low and did not differ between
Fig. 1 Accumulated feed intake (g/pig) from day 1 to 13 postweaning
of piglets fed CONd or CDCd prestarter diet. Values are least squares
means ± SEM, n = 18 per treatment. CONd, prestarter diet; CDCd,
prestarter diet supplemented with 60 mg of chenodeoxycholic acid
per kg of initial BW
Table 2 Performance of piglets fed CONd or CDCd prestarter dieta
Treatments SEMb P >
FCONd CDCd
0 to 15 days of study
n 6 6
BW d 0 (kg) 6.3 6.3 0.21 0.83
BW d 14 (kg) 8.4 8.5 0.21 0.39
Average daily gain (g/d) 150 160 13.9 0.63
Average daily feed intake (g/d) 211 214 10.0 0.81
0 to 35 days of study
n 12 12
BW d 0 (kg) 6.2 6.2 0.53 0.44
BW d 35 (kg) 18.5 17.6 0.53 0.44
Average daily gain (g/d) 352 325 21.7 0.38
Average daily feed intake (g/d) 527 479 24.6 0.18
Feed:Gain 1.45 1.21 0.19 0.40
Diarrhoeac (n) 3 3 — 0.46
aData are least squares means. CONd, prestarter diet; CDCd, prestarter diet
supplemented with 60 mg chenodeoxycholic acid per kg of initial BW
bPooled SEM
cNumber of events (P > χ2)
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behavior and signs of adverse treatment effects were not
observed during the study.Plasma GLP-2
Although mean plasma GLP-2 did not differ between
treatments (Fig. 3A), feeding CDCd tended (P < 0.07) toFig. 2 Accumulated feed intake (g/pig) from week 1 to 5 postweaning
of piglets fed CONd or CDCd prestarter diet. Values are least squares
means ± SEM, n= 12 per treatment. CONd, prestarter diet; CDCd,
prestarter diet supplemented with 60 mg of chenodeoxycholic acid
per kg of initial BWincrease the concentration of circulating GLP-2 by 39 %
on day 14 after 2 weeks of treatment exposure (Fig. 3B).
Intestinal growth and morphology
The inclusion of CDC in the prestarter diet tended to
enhance the weight of the large intestine (P < 0.10) but
did not modify the size (weight and length) of the small
intestine (Table 3). In addition, the morphology of the
mucosa from the jejunum and ileum was similar be-
tween treatments, with the exemption of the ileal crypts
that were deeper (P < 0.04) in pigs fed CDC (Table 4).
Intestinal gene expression
The feeding of CDCd during the 14 days that followed
EW did not modify the relative concentration of mRNA
transcripts from genes examined in the jejunal mucosa
(data not shown). Although expression of OCLN, GLP-
2R, ASBT, EGFR and GCG was similar between groups
(data not shown), the expression of ZON-1 (P < 0.02),
TNF-α (P < 0.02), IL-10 (P < 0.006), and IL-6 (P < 0.01)
increased 1.5, 1.9, 2.2 and 2.4 folds, respectively, in the
ileum of CDCd-fed piglets relative to their CONd coun-
terparts (Fig. 4).
Discussion
Feeding piglets a cereal-based diet supplemented with CDC
for 2 weeks after EW induced genes involved in the barrier
function and protection of the intestinal mucosa with mar-
ginal effects on the concentration of circulating GLP-2 and
mass of the intestine. The enteroprotective action of CDC
Fig. 3 Changes in mean plasma (A) and circulating (B) GLP-2 concentration in piglets fed CONd or CDCd prestarter diet. Values are least squares
means, n = 6 per treatment, A. SEM = 0.033. B. SEM = 0.056, +P = 0.07. CONd, prestarter diet; CDCd, prestarter diet supplemented with 60 mg of
chenodeoxycholic acid per kg of initial BW
Table 4 Intestinal morphology of piglets fed CONd or CDCd
prestarter dieta
de Diego-Cabero et al. BMC Veterinary Research  (2015) 11:111 Page 5 of 8was not associated with changes in food intake and BW
gain either during the period of CDC supplementation or
after withdrawal of CDC from the diet. The low incidence
of diarrhea observed in both treatment groups suggests that
keeping pigs in individual pens under high sanitary condi-
tions might have hindered improvements in animal per-
formance otherwise mediated by CDC. Taken together,
data indicate that the oral administration of bile acids to
weaned pigs has the potential to improve the protection of
the intestinal mucosa independently of relevant changes in
gut growth.
Weaning-induced intestinal atrophy and dysfunction
are associated with a transient decrease in circulating
GLP-2 [4, 5]. In a previous study, we have showed that
the intragastric administration of a single dose of CDC
to piglets during the first 6 days after EW remarkably in-
creased the plasma concentration of endogenous GLP-2
but that this response tended to enhance only the length
and weight of the ileum [16]. Thus, we speculated thatTable 3 Intestinal weight and length of piglets fed CONd or
CDCd prestarter dieta
Treatments SEM P >
FCONd CDCd
Organ weight (g/kg BW)
Duodenum + jejunum 32.8 34.7 1.32 0.33
Ileum 8.0 7.9 0.30 0.80
Small intestine 40.9 42.7 1.45 0.41
Large intestine 16.1 17.9 0.71 0.10
Whole intestine 57.0 60.5 1.64 0.16
Organ length (cm/kg BW)
Duodenum + jejunum 100 102 4.8 0.83
Ileum 19.8 18.2 0.70 0.13
Small intestine 120 120 4.9 0.96
aData are least squares means, n = 6. CONd, prestarter diet; CDCd, prestarter
diet supplemented with 60 mg chenodeoxycholic acid per kg of initial
body weightsupplementing the postweaning diet with CDC with the
aim of distributing its enteral supply throughout the day
may augment the nutrient-dependent secretion of GLP-
2 and improve its efficacy to preserve gut integrity im-
mediately after EW. We observed that plasma GLP-2
tended to increase at the end of the period of exposure
to CDC on day 14, when food intake increased on aver-
age by 160 g/d (178 %) relative to the first postweaning
week. Coincidentally, in our previous study piglets con-
sumed during the first 6 days after EW about 66 % more
feed (+48 g/d) than in the present study [16]. It seems
therefore that there is a minimum of enteral nutrition
required for CDC to potentiate the release of GLP-2 in
animals fed solid diets. Although this effect was paral-
leled by a deepening of the ileal crypts, which is a dis-
tinctive trophic action of GLP-2 [5], only the mass of theTreatments SEM P >
FCONd CDCd
Jejunum
Villus height (μm) 454 419 23.8 0.31
Crypt depth (μm) 186 181 5.6 0.59
Villus:Crypt ratio 2.5 2.3 0.14 0.48
Intraepithelial lymphocytes (n/villus) 30.7 29.2 1.77 0.55
Goblet cells (n/villus) 6.8 7.0 0.44 0.70
Ileum
Villus height (μm) 403 410 21.6 0.82
Crypt depth (μm) 133 153 6.0 0.04
Villus:Crypt ratio 3.1 2.7 0.16 0.13
Intraepithelial lymphocytes (n/villus) 27.7 30.3 1.60 0.27
Goblet cells (n/villus) 6.9 7.5 0.49 0.37
aData are least squares means, n = 6. CONd, prestarter diet; CDCd, prestarter
diet supplemented with 60 mg chenodeoxycholic acid per kg of initial
body weight
Fig. 4 Relative abundance of ZON-1, TNF-α, IL-10 and IL-6 mRNA in
the ileum of piglets fed CONd or CDCd prestarter diet. Relative gene
expression values are fold change of the CDCd diet relative to the
CONd which was set to be 1.0 (n = 6 per treatment). Bars indicate
the 95 % confidence interval (Fold change up - Fold change low).
CONd, prestarter diet; CDCd, prestarter diet supplemented with 60 mg of
chenodeoxycholic acid per kg of initial BW; ZON-1, zonula occludens 1;
TNF-α, tumor necrosis factor alpha; IL-10, interleukin 10; IL-6, interleukin 6.
*P < 0.05, **P < 0.01
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enteral administration of CDC prevented gut atrophy in
newborn piglets fed via parenteral [15]. In line with our
findings, however, recent studies also observed modest
enlargements of the epithelium of the intestine of
enterally-fed weanling pigs in response to prolonged
treatment with exogenous GLP-2 [11, 12]. Collectively,
data indicate that the intestine of pigs remains respon-
sive to the trophic effect of bile acids after weaning, an
action presumably mediated by GLP-2, but that the
magnitude of this effect is rather small and likely irrele-
vant from a developmental standpoint. However, one
cannot rule out that the deepening of crypts induced by
CDC might accelerate the recovery of the intestinal mu-
cosa function after weaning and contribute to maintain
TJ and adequate enterocyte turnover.
A critical function of the intestinal epithelium is to
form a dynamic physical barrier to luminal contents to
protect the host from infection and chronic exposure to
inflammatory stimuli. Adjacent mucosal cells accomplish
this by interacting through TJ proteins that are connected
to the actin cytoskeleton and regulate the intestinal para-
cellular permeability [27]. Importantly, mounting evidence
links increased gut permeability with intestinal inflamma-
tion, systemic immune activation, and disease progression
in humans and animals [28]. Because EW dysregulates in-
testinal permeability in pigs [3, 29], targeting TJ proteins
may illuminate ways to maintain the integrity of theintestinal barrier and thereby improve piglet health, growth,
and welfare during the weaning period. Based on this pre-
diction and the notion that bile acids [17, 18] and GLP-2
[30] regulate the expression and (or) cellular distribution of
TJ proteins, we decided to examine the impact of dietary
supplementation with CDC on the expression of some
genes involved in the control of the barrier function of the
intestinal mucosa. We found that feeding CDCd resulted in
proinflammatory (i.e.,TNF-α and IL-6 expression) and anti-
inflammatory (i.e., IL-10 expression) responses that were as-
sociated with increased concentration of ZON-1 transcripts
in the epithelium of the distal small intestine. Considering
that during the development of intestinal inflammation
TNF-α disrupts TJ [31] whereas IL-10 antagonizes its ac-
tion [32], it seems reasonable to suggest that CDC triggered
a homeostatic immune response that ultimately appeared
to enhance the integrity of TJ of the intestinal epithelium.
The question as to whether these effects were mediated
directly by CDC via activation of the bile acid sensors
TGR5 [18] and farnesoid X-activated receptor (FXR) [17]
or indirectly via enhanced released of GLP-2 [30] cannot be
addressed with data reported herein. However, the observa-
tion that the anti-inflammatory action of GLP-2 involves
suppression of both crypt-cell proliferation and inflamma-
tory cytokines through a mechanism unrelated to Th2 cyto-
kines such as IL-10 [33], suggests that the tolerogenic
response triggered by CDC was not associated with GLP-2.
Yet, it is more important to note that in a recent study with
early-weaned pigs weaning disrupted intestinal permeability
partly by repressing the expression of TJ proteins, including
ZON-1, and that this effect lasted for 14 days postweaning
albeit the morphology of the intestinal mucosa was fully re-
covered by then [34]. Therefore, our findings support the
proposal that the oral administration to pigs of bile acids,
or compounds that mimic their action, holds potential for
enhancing the integrity of the mucosal barrier at weaning
and beyond this critical time.
It is widely accepted that disorders caused by EW, in-
cluding increased susceptibility to diarrhea and growth
retardation, mainly result from the transient absence of
feed consumption that follows EW [1]. Expectably, sup-
plementing the postweaning diet with CDC compre-
hended the risk of aggravating EW-induced anorexia
because of reduced diet acceptability and (or) enhanced
satiety mediated centrally by GLP-2 [35]. We found,
however, that feeding CDCd did not affect the onset of
feed intake following EW nor the amount of feed con-
sumed during the 5-weeks study. Likewise, feed intake
of weanling pigs was not affected when the plasma con-
centration of GLP-2 was increased via the intragastric
infusion of CDC [16] or the administration of exogenous
GLP-2 at a supraphysiological dose [11]. Despite the ab-
sence of anorectic effects, the aforementioned entero-
protective impact of feeding CDCd did not translate into
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of diarrhea). As suggested before, the high sanitary condi-
tions under which this study was conducted might have
accounted for such results. Certainly, the efficacy of ex-
ogenous GLP-2 for improving gut integrity during EW was
most evident when pigs developed severe diarrhea [12].
Furthermore, bile acid-mimicking compounds administered
orally to mice suppressed intestinal inflammation and signs
of diarrhea in models of chemically-induced colitis [18, 36].
Thus, available data provide a rationale for exploring the
value of bile acids and compounds that mimic their action
as dietary supplements to improve performance of pigs
under situations of increased incidence of enteric disorders.
Conclusions
Supplementing the diet of early-weaned pigs with CDC
enhanced the expression of genes involved in the protec-
tion and barrier function of the mucosa of the distal
small intestine. These effects, however, were only associ-
ated with a trend towards increased concentration of
endogenous GLP-2 and intestinal growth. Even though
dietary supplementation with CDC did not affect feed
intake, the high sanitary conditions that prevailed in this
study might have negated improvements in piglet per-
formance resulting from the enteroprotective action of
CDC. Results from this study warrant further research
to examine the use of bile acids and compounds that
mimic their action as dietary interventions to improve
gut health and performance of pigs under situations of
increased susceptibility to enteric inflammation and in-
fection (e.g., poor environmental hygiene, increased mi-
crobial exposure, physical stress, etc.).
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